Hemgenix is given ‘conditional authorisation’. Consequently the eu Medicines Agency resolved that the benefits of Hemgenix are greater than its challenges, but the corporate must provide supplemental proof after authorisation.As for all medicines, data on using Hemgenix are continually monitored. Suspected Unwanted effects documented with Hemge